SCHEMBL18752182

SCHEMBL18752182

CCc1ccc(Cn2cc(C(=O)NCc3ccc4c(N)nccc4c3)c(C(C)C)n2)cc1

nearest known ligand 0.80

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ KLKB1 P03952 20/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16247125 0.89 KLKB1 (1.00) KLKB1
SCHEMBL18752184 0.82 KLKB1 (0.65) KLKB1
SCHEMBL17693889 0.82 KLKB1 (1.00) KLKB1
SCHEMBL21180324 0.80 KLKB1 (0.74) KLKB1
SCHEMBL17696322 0.78 KLKB1 (1.00) KLKB1
SCHEMBL21177966 0.78 KLKB1 (0.71) KLKB1
SCHEMBL18725266 0.77 KLKB1 (0.76) KLKB1
SCHEMBL17685624 0.76 KLKB1 (1.00) KLKB1
SCHEMBL17693887 0.76 KLKB1 (1.00) KLKB1
Hydrochloric Acid SCHEMBL16247025 0.76 KLKB1 (0.98) KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3305778-B1 INHIBITORS OF PLASMA KALLIKREIN KALVISTA PHARMACEUTICALS LTD (GB) 2022-01-19 — — EP disclosed
EP-3305778-A1 INHIBITORS OF PLASMA KALLIKREIN Kalvista Pharmaceuticals Limited (GB) 2018-04-11 — — EP disclosed
EP-2999697-B1 HETEROCYCLIC DERIVATES KALVISTA PHARMACEUTICALS LTD (GB) 2017-04-19 — — EP disclosed
Send feedback